Study Unveils Environmental and Genetic Links to Depressive Symptoms


In a significant breakthrough, a new study published in Nature Mental Health sheds light on the intricate connections between environmental exposures, and genetic links to depressive symptoms.

Conducted by Wang Zhiyang and a team of researchers, the study explores the concept of the “exposome” — encompassing all environmental influences — to gain deeper insights into the vulnerabilities associated with depression, particularly in the context of Major Depressive Disorder (MDD) in Western Europe.

The research delves into the high prevalence of MDD in Western Europe, particularly among adolescents, a trend that has seen a concerning surge during the COVID-19 pandemic.

Utilizing the FinnTwin12 cohort dataset, which includes twins born in Finland between 1983 and 1987, the study analyzes 3025 participants in young adulthood (mean age approximately 22 years) and 4127 participants at age 17.

Two key methods are employed: Exposome-wide Association Studies (ExWAS) and bivariate twin modeling. ExWAS, akin to genome-wide association studies but focusing on environmental factors, identifies 29 exposures significantly associated with depressive symptoms in young adulthood and 46 exposures at age 17, spanning 12 distinct environmental domains. These domains encompass factors such as air pollution, family dynamics, and life events.

Familial exposures emerge as the most influential factors, highlighting the profound impact of family dynamics and relationships on the development and persistence of depressive symptoms during late adolescence and early adulthood.

However, these exposures are not directly linked to the incidence of Major Depressive Disorder in young adulthood, and intriguingly, environmental effects exert a more significant impact than genetic effects in males compared to females.

Bivariate twin modeling uncovers a complex interplay between genetic and environmental factors and depressive symptoms. While both genetic and environmental factors significantly contribute to the variance in depressive symptoms, genetics exerts a slightly larger influence.

This suggests that environmental factors, as part of one’s exposome, are intricately associated with genetic aspects. The study underscores how family influences, including happiness levels and domestic issues, can be inherited through genes and shared family environments.

The findings emphasize the critical need to comprehend the interaction between genes and the environment, elucidating how specific genetic traits can manifest in diverse health outcomes based on environmental influences.

However, the researchers acknowledge a limitation in the study – the relatively small sample size compared to other ExWAS research. Due to this constraint, the data could not be stratified by sex, as doing so would significantly reduce the sample size.

Despite this limitation, the study represents a pioneering effort in unraveling the complex dynamics between genetic predisposition, environmental exposures, and mental health outcomes.

The study, titled “The effect of environment on depressive symptoms in late adolescence and early adulthood: an exposome-wide association study and twin modeling,” features contributions from researchers Wang Zhiyang, Stephanie Zellers, Alyce M. Whipp, Marja Heinonen-Guzejev, Maria Foraster, Jordi Júlvez, Irene van Kamp, and Jaakko Kaprio.

It marks a significant step forward in understanding the intricate web of factors contributing to depressive symptoms, offering valuable insights for future research and mental health interventions.

— Share —

— About the Author —

Leave a Reply

Up Next

Study Reveals Significant Genetic Link Between Treatment-Resistant Depression and Family History

In a groundbreaking study published in the journal JAMA Psychiatry, researchers have uncovered a substantial genetic link between treatment-resistant depression (TRD) and family history.

Led by Dr. Cheng-Ta Li, a professor of medicine at the National Yang-Ming Chiao Tung University in Taipei, Taiwan, the study utilized extensive national health insurance data to investigate the transmission of TRD across generations and its association with other psychiatric disorders.

The findings of the study are particularly significant, as they shed light on the hereditary nature of TRD and its implications for early intervention and treatment.

Up Next

FDA Clears Prescription Digital Therapeutic for Adults with Major Depressive Disorder

The FDA has recently cleared a groundbreaking prescription digital therapeutic, known as Rejoyn, for the treatment of major depressive disorder (MDD) symptoms in adults. This innovative therapy, developed by Otsuka Pharmaceutical Co. Ltd. in collaboration with Click Therapeutics Inc., aims to provide adjunctive care for individuals who have been prescribed antidepressants as part of clinician-managed outpatient treatment.

Rejoyn is a 6-week treatment program designed to assist individuals aged 22 years and older in regulating their emotions through a combination of clinically validated cognitive training exercises and therapeutic lessons.

The therapy utilizes digital platforms to deliver pe

Up Next

Sweet Science: How Chocolate’s Theobromine May Aid Weight Loss and Alzheimer’s Prevention

A recent study conducted by researchers at Zhengzhou University in China suggests that indulging in chocolate could offer various health benefits, including weight loss assistance and Alzheimer’s prevention.

Published in the Journal of Functional Foods, the study highlights the potential of a chemical compound found in chocolate called theobromine to positively impact both the body and the brain.

Theobromine, present in cocoa beans, boasts anti-inflammatory properties and is rich in antioxidants, making it beneficial for brain health. According to scientists, this compound can protect against Alzhei

Up Next

New Study Finds High Genetic Risk for Obesity May Require Over 14,500 Daily Steps

A recent study published in JAMA Network Open reveals a significant association between genetic risk for obesity and the amount of physical activity required to mitigate the risk.

Led by Dr. Evan Brittain, associate professor of medicine at Vanderbilt University Medical Center, the study analyzed data from 3,124 participants in the National Institutes of Health’s All of Us Research Program to explore the link between genetic predisposition to obesity and recommended step counts for reducing the genetic risk of developing the condition.

Findings from the study indicate that individuals with a higher genetic risk of obesity may need to undertake more physical activity

Up Next

Ketogenic Diets Show Promise for Bipolar Disorder and Schizophrenia Treatment, Stanford Study Finds

A recent study led by researchers at Stanford University suggests that ketogenic diets may offer benefits for individuals with bipolar disorder and schizophrenia, shedding light on the potential role of diet in managing serious mental illnesses.

The findings, published in Psychiatry Research, highlight the positive impact of a ketogenic regime on both psychiatric outcomes and metabolic syndromes commonly associated with these conditions.

Unlike traditional diets, ketogenic diets are characterized by high fat, moderate protein, and very low carbohydrate intake. The study, led by Dr. Shebani Sethi, a clinical ass

Up Next

Trend Alert: “Patientsplaining” on the Rise as Americans Share Online Health Research with Doctors

A recent survey conducted by market research company OnePoll for Vimergy sheds light on a growing trend among Americans dubbed as “patientsplaining,” where individuals discuss their online health findings with their doctors. The survey, which included 2,000 general population Americans, explored how people invest time in their health and interact with healthcare professionals.

According to the findings, seven in 10 Americans (68%) admit to engaging in “patiensplaining,” wherein they share their online health research with their doctors. This behavior reflects a broader trend of increased interest and involvement in personal health matters, with three in four respondents (77%) reporting that they conduct health-related research in their spare time.

Prevalence of Patientsplaining

Up Next

New Study Raises Concerns About Impact of Metformin on Offspring’s Brain Development During Pregnancy

In a groundbreaking study shedding light on the complexities of managing gestational diabetes risks, researchers from the German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE) have uncovered potential concerns regarding the impact of metformin on offspring’s brain development during pregnancy.

Published in the prestigious journal Molecular Metabolism, this research underscores the urgent need for preventive strategies and careful consideration of treatment options for pregnant individuals with diabetes.

Rising Cases of Gestational Diabetes

With the prevalence of gestational diabetes and metabolic disorders on the rise during pregnancy, the prescription of metformin has become increasingly common. However, the effects of this oral antidiabetic medication on the developing brain of